PURPOSE: To determine whether taurine transporter (TauT) activity and expression are regulated by hyperosmolarity in RPE, ganglion, and Müller cells. METHODS: Uptake of taurine was measured in ARPE-19 cells cultured in DMEM-F12 medium without or with the addition of 50 mM NaCl or 100 mM mannitol. The kinetics of the transport were analyzed. RT-PCR and Northern and Western blot analyses were used to assess TauT mRNA and protein levels. The influence of hyperosmolarity on the uptake of taurine, myo-inositol, and gamma-aminobutyric acid GABA was studied in RPE, RGC-5, and rMC1 cells. RESULTS: TauT activity was abundant in RPE and was stimulated (3.5-fold) when the cells were exposed to hyperosmolar conditions (DMEM-F12 culture medium plus 50 mM NaCl or 100 mM mannitol). Peak stimulation of taurine uptake occurred after 17 hours of exposure to hyperosmolar medium. Kinetic analysis revealed that the hyperosmolarity-induced stimulation was associated with an increase in V(max) of TauT with no change in K(m). TauT mRNA and protein levels increased in RPE cells exposed to hyperosmolar conditions. Hyperosmolarity also stimulated the uptake of myo-inositol ( approximately 15-fold); GABA uptake was influenced less markedly. Immunofluorescence and functional studies showed that TauT is present in cultured RGC-5 and rMC1 cells. TauT activity was robust in these cells in normal osmolar conditions and increased by approximately twofold in hyperosmolar conditions. CONCLUSIONS: These studies provide the first evidence that hyperosmolarity regulates TauT activity and expression in RPE and that TauT is present in ganglion and Müller cells and is regulated by hypertonicity. The data are relevant to diseases such as diabetes, macular degeneration, and neurodegeneration, in which retinal cell volumes may fluctuate dramatically.
PURPOSE: To determine whether taurine transporter (TauT) activity and expression are regulated by hyperosmolarity in RPE, ganglion, and Müller cells. METHODS: Uptake of taurine was measured in ARPE-19 cells cultured in DMEM-F12 medium without or with the addition of 50 mM NaCl or 100 mM mannitol. The kinetics of the transport were analyzed. RT-PCR and Northern and Western blot analyses were used to assess TauT mRNA and protein levels. The influence of hyperosmolarity on the uptake of taurine, myo-inositol, and gamma-aminobutyric acidGABA was studied in RPE, RGC-5, and rMC1 cells. RESULTS:TauT activity was abundant in RPE and was stimulated (3.5-fold) when the cells were exposed to hyperosmolar conditions (DMEM-F12 culture medium plus 50 mM NaCl or 100 mM mannitol). Peak stimulation of taurine uptake occurred after 17 hours of exposure to hyperosmolar medium. Kinetic analysis revealed that the hyperosmolarity-induced stimulation was associated with an increase in V(max) of TauT with no change in K(m). TauT mRNA and protein levels increased in RPE cells exposed to hyperosmolar conditions. Hyperosmolarity also stimulated the uptake of myo-inositol ( approximately 15-fold); GABA uptake was influenced less markedly. Immunofluorescence and functional studies showed that TauT is present in cultured RGC-5 and rMC1 cells. TauT activity was robust in these cells in normal osmolar conditions and increased by approximately twofold in hyperosmolar conditions. CONCLUSIONS: These studies provide the first evidence that hyperosmolarity regulates TauT activity and expression in RPE and that TauT is present in ganglion and Müller cells and is regulated by hypertonicity. The data are relevant to diseases such as diabetes, macular degeneration, and neurodegeneration, in which retinal cell volumes may fluctuate dramatically.
Authors: M A S Di Leo; S A Santini; S Cercone; D Lepore; N Gentiloni Silveri; S Caputo; A V Greco; B Giardina; F Franconi; G Ghirlanda Journal: Amino Acids Date: 2002 Impact factor: 3.520
Authors: Jennifer R Chao; Kaitlen Knight; Abbi L Engel; Connor Jankowski; Yekai Wang; Megan A Manson; Haiwei Gu; Danijel Djukovic; Daniel Raftery; James B Hurley; Jianhai Du Journal: J Biol Chem Date: 2017-06-14 Impact factor: 5.157
Authors: B Renee Bozard; Preethi S Ganapathy; Jennifer Duplantier; Barbara Mysona; Yonju Ha; Penny Roon; Robert Smith; I David Goldman; Puttur Prasad; Pamela M Martin; Vadivel Ganapathy; Sylvia B Smith Journal: Invest Ophthalmol Vis Sci Date: 2010-01-06 Impact factor: 4.799
Authors: Firas Jammoul; Qingping Wang; Rima Nabbout; Caroline Coriat; Agnès Duboc; Manuel Simonutti; Elisabeth Dubus; Cheryl M Craft; Wen Ye; Stephen D Collins; Olivier Dulac; Catherine Chiron; José A Sahel; Serge Picaud Journal: Ann Neurol Date: 2009-01 Impact factor: 10.422
Authors: T Arsenijevic; A Vujovic; F Libert; A Op de Beeck; A Hébrant; S Janssens; F Grégoire; A Lefort; N Bolaky; J Perret; L Caspers; F Willermain; C Delporte Journal: Cell Death Dis Date: 2013-06-06 Impact factor: 8.469
Authors: Neeta Khandekar; Mark D P Willcox; Sharon Shih; Peter Simmons; Joseph Vehige; Qian Garrett Journal: Mol Vis Date: 2013-09-19 Impact factor: 2.367